The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Diabetes, bone and glucose-lowering agents: basic biology
Open accessAbstract
Skeletal fragility often accompanies diabetes and does not appear to correlate with low bone mass or trauma severity in individuals with diabetes. Instead (and in contrast to those with osteoporotic bone disease), bone remodelling and bone turnover are compromised in both type 1 and type 2 diabetes, contributing to defective bone material quality. This review is one of a pair discussing the relationship between diabetes, bone and glucose-lowering agents; an accompanying review is provided in this issue of Diabetologia by Ann Schwartz (DOI: 10.1007/s00125-017-4283-6 ). This review presents basic science evidence that, alongside other organs, bone is affected in diabetes via impairments in glucose metabolism, toxic effects of glucose oxidative derivatives (advance glycation end-products [AGEs]), and via impairments in bone microvascular function and muscle endocrine function. The cellular and molecular basis for the effects of diabetes on bone are discussed, as is the impact of diabetes on the stem cell niche and fracture healing. Furthermore, the safety of clinically approved glucose-lowering therapies and the possibility of developing a single therapy that would be beneficial for both insulin sensitisation and diabetes bone syndrome are outlined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism
Ferron, M., Wei, J., Yoshizawa, T., Del Fattore, A., DePinho, R. A., Teti, A., Ducy, P., & Karsenty, G. (2010) · Cell · doi:10.1016/j.cell.2010.06.003 · Cited by 1,123
Nilsson, A. G., Sundh, D., Johansson, L., Nilsson, M., Mellström, D., Rudäng, R., Zoulakis, M., Wallander, M., Darelid, A., & Lorentzon, M. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3057 · Cited by 217
Tanikawa, T., Okada, Y., Tanikawa, R., & Tanaka, Y. (2009) · Journal of Vascular Research · doi:10.1159/000226225 · Cited by 191 · cited 1×
“VSMC markers and activation of an osteoblast-like programme, including expression of Runx2 and osteocalcin and increased enzymatic activity of alkaline phosphatase, result in VSMC calcification [32].”
Background
Cited by
Bone fragility in diabetes: novel concepts and clinical implications
Hofbauer, L. C., Busse, B., Eastell, R., Ferrari, S., Frost, M., Müller, R., Burden, A. M., Rivadeneira, F., Napoli, N., & Rauner, M. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00347-8 · Cited by 440
Xiong, Y., Lin, Z., Bu, P., Yu, T., Endo, Y., Zhou, W., Sun, Y., Cao, F., Dai, G., Hu, Y., et al. (2023) · Advanced Materials · doi:10.1002/adma.202212300 · Cited by 370
mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
Walters, H. E., & Cox, L. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082325 · Cited by 85
Kong, Q.-X., Ruan, Q., Fan, C., Liu, B.-L., Reng, L.-P., & Xu, W. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0031 · Cited by 22
Metadata
- Authors
- Lecka-Czernik, B.
- Venue
- Diabetologia
- Published
- 2017-04-22
- Volume
- 60
- Issue
- 7
- Pages
- 1163-1169
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2605537746
- Cited by
- 208
- References
- 3
- FWCI
- 10.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetes, bone and glucose-lowering agents: basic biology. https://app.cochat.ai/papers/10.1007/s00125-017-4269-4
- The paper
- Lecka-Czernik, B. (2017). Diabetes, bone and glucose-lowering agents: basic biology. Diabetologia. https://doi.org/10.1007/s00125-017-4269-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.